Recombinant DMA Advisory Osnimittce - 3/3^/94 
Sarah Carr, OD 
Barry Goldspiel, CC 
Betsey Herpin, NIAID 
Christine Ireland, OD 
Susan Jenks, NCI 
H. Clifford Lane, NIAID 
Becky Lawson, OD 
Martha Lawson, NIAID 
Sachiko Kajigaya, NHLBI 
Dai Katayose, NCI 
Masako Kawase, NHLBI 
Catherine McKeon, NIDDK 
David Nelson, NCHGR 
Prem Seth, NCI 
Thomas Shih, OD 
Robert Walker, NIAID 
Debra Wilson, OD 
Jim Yang, NCI 
Others: 
Paul Aebersold, Food and Drug Administration 
W, French Anderson, University of Southern California 
Jack Barber, Viagene, Inc. 
Bridget Binko, Cell Genesys 
Kenneth Brigham, Vanderbilt University 
Gracia Buffleben, ACT UP/Golden Gate 
Angelo Canonico, Vanderbilt University 
Jeff Carey, Genetic Therapy, Inc. 
Joy Cavagnaro, Food and Drug Administration 
Henry Chang, Shared Medical Research Foundation 
Lan Chang, Institute of Biomedical Science 
Yawen Chiang, Genetic Therapy, Inc. 
Jon Conary, Vanderbilt University 
Rathin Das, Miles, Inc. 
Mitchell Finer, Cell Genesys 
Ralph Freedman, M. D. Anderson Cancer Center 
George Gray, Vical, Inc. 
Joanna Hales, Cell Genesys 
Lowell Harmison, Self-Employed 
Evan Hersh, University of Arizona 
Morio Hibino, Kennedy Institute of Ethics, Georgetown University 
Doug Hickman, T. Rowe Price 
Dan Hoth, Cell Genesys 
Allen Kamer, The Pink Sheet 
Catherine Killion, Baxter Healthcare Corporation 
[ 14 ] 
Recombinant DNA Research, Volume 19 
